The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s second, approved IGF-1R antibody drug.
After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers A personal quest and progress in brain science finally put a name on baffling behaviors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback